AU5545400A - Estrogen receptor - Google Patents
Estrogen receptorInfo
- Publication number
- AU5545400A AU5545400A AU55454/00A AU5545400A AU5545400A AU 5545400 A AU5545400 A AU 5545400A AU 55454/00 A AU55454/00 A AU 55454/00A AU 5545400 A AU5545400 A AU 5545400A AU 5545400 A AU5545400 A AU 5545400A
- Authority
- AU
- Australia
- Prior art keywords
- estrogen receptor
- estrogen
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9913649.1A GB9913649D0 (en) | 1999-06-11 | 1999-06-11 | Estrogen receptor |
GB9913649 | 1999-06-11 | ||
PCT/GB2000/002283 WO2000076529A2 (en) | 1999-06-11 | 2000-06-12 | Use of estrogen receptor agonists or antagonists for treating growth, bone disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5545400A true AU5545400A (en) | 2001-01-02 |
Family
ID=10855195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU55454/00A Abandoned AU5545400A (en) | 1999-06-11 | 2000-06-12 | Estrogen receptor |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1185287A2 (en) |
AU (1) | AU5545400A (en) |
CA (1) | CA2376441A1 (en) |
GB (1) | GB9913649D0 (en) |
WO (1) | WO2000076529A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA83620C2 (en) | 2001-12-05 | 2008-08-11 | Уайт | Substituted benzoxazoles and analogues as estrogenic agents |
US6835745B2 (en) | 2002-01-15 | 2004-12-28 | Wyeth | Phenyl substituted thiophenes as estrogenic agents |
AU2005282554A1 (en) | 2004-09-07 | 2006-03-16 | Wyeth | 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL109990A (en) * | 1993-06-21 | 1999-06-20 | Lilly Co Eli | Materials and methods for screening anti-osteoporosis agents |
JPH10512235A (en) * | 1994-07-20 | 1998-11-24 | セルトリックス ファーマシューティカルズ,インコーポレイテッド | IGF / IGFBP complex for promoting bone formation and regulating bone remodeling |
HN1996000101A (en) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | COMBINED THERAPY FOR OSTEOPOROSIS |
WO1998025623A1 (en) * | 1996-12-09 | 1998-06-18 | Merck & Co., Inc. | Methods and compositions for preventing and treating bone loss |
-
1999
- 1999-06-11 GB GBGB9913649.1A patent/GB9913649D0/en not_active Ceased
-
2000
- 2000-06-12 CA CA002376441A patent/CA2376441A1/en not_active Abandoned
- 2000-06-12 WO PCT/GB2000/002283 patent/WO2000076529A2/en not_active Application Discontinuation
- 2000-06-12 AU AU55454/00A patent/AU5545400A/en not_active Abandoned
- 2000-06-12 EP EP00940530A patent/EP1185287A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000076529A3 (en) | 2001-07-12 |
CA2376441A1 (en) | 2000-12-21 |
EP1185287A2 (en) | 2002-03-13 |
WO2000076529A2 (en) | 2000-12-21 |
GB9913649D0 (en) | 1999-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1199600A (en) | Estrogen receptor ligands | |
AU1173201A (en) | Skin-gripper | |
AU3092999A (en) | Digital-timeshare-exchange | |
AU5095000A (en) | Receptor interacting protein rip3 | |
AU1104301A (en) | Primary n-hydroxylamines | |
AU7132898A (en) | Edg-1-like receptor | |
IL146151A0 (en) | Human-g-protein receptor | |
AU4115400A (en) | Short-circuiter | |
AU1073501A (en) | Histamine receptor | |
AU2804600A (en) | Arylaminoalkylamides | |
AU2023701A (en) | Sketcher | |
AU1551901A (en) | Semaphorin receptor | |
AU2699800A (en) | Organoceramics | |
AU6642900A (en) | Improved materials for mycoculture | |
AU2140000A (en) | Feeder device | |
AU2001223882A1 (en) | Receptor | |
AUPQ563400A0 (en) | Novel receptor | |
AU5545400A (en) | Estrogen receptor | |
AU3821800A (en) | Auxiliary device for serving | |
AU2001249359A1 (en) | Constitutive androstane receptor | |
AU1901801A (en) | Glucofuranoses | |
AU2582200A (en) | Windturbine | |
AU1915601A (en) | Periotome | |
AU5205000A (en) | Front-flushing toilet | |
AU5235600A (en) | Assays |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |